So-Yoon Won

Microglia of Prefrontal White Matter in Suicide

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions

Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats

Macrophages in immunoregulation and therapeutics

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response

Dendritic Cell Metabolism and Function in Tumors

Targeting immunometabolism as an anti-inflammatory strategy

Gut microbiome and health: mechanistic insights

Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy

PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment

Cannabinoids and the expanded endocannabinoid system in neurological disorders

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Neuroinflammation: the devil is in the details

Oxidative Stress in Ageing and Chronic Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting Oxidative Stress and Chronic Inflammation

The Therapeutic Potential of Naringenin: A Review of Clinical Trials

Controlled Activation of TRPV1 Channels on Microglia to Boost Their Autophagy for Clearance of Alpha‐Synuclein and Enhance Therapy of Parkinson's Disease

Photothermal Nanomaterials: A Powerful Light-to-Heat Converter

Important Flavonoids and Their Role as a Therapeutic Agent

Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration

Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson’s disease

Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease

Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation

Prothrombin kringle‐2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation

CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease

Inhibition of Microglia-Derived Oxidative Stress by Ciliary Neurotrophic Factor Protects Dopamine Neurons In Vivo from MPP+ Neurotoxicity